Drug Treatment of M. Avium-Intracellulare in AIDS

Young, Lowell S.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Research and Development Contracts (N01)
• Project #: N01AI042545-003
• Application #: 3593897
• Project Start: 1984-07-23
• Project End: 1987-07-22
• Budget Start: 1985-04-01
• Budget End: 1986-07-22
• Fiscal Year: 1985

Institution

• Name: University of California Los Angeles
• Type: Schools of Medicine
• DUNS #: 119132785
• City: Los Angeles
• State: CA
• Country: United States
• Zip Code: 90095

Publications

Bermudez, L E; Young, L S; Gupta, S (1990) 1,25 Dihydroxyvitamin D3-dependent inhibition of growth or killing of Mycobacterium avium complex in human macrophages is mediated by TNF and GM-CSF. Cell Immunol 127:432-41

Bermudez, L E; Young, L S (1990) Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex. J Leukoc Biol 48:67-73

Bermudez, L E; Young, L S (1989) Oxidative and non-oxidative intracellular killing of Mycobacterium avium complex. Microb Pathog 7:289-98

Bermudez, L E; Stevens, P; Kolonoski, P et al. (1989) Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor. J Immunol 143:2996-3000

Bermudez, L E; Young, L S (1988) Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 140:3006-13